Literature DB >> 16806280

MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration.

Osamu Ishibashi1, Satoru Niwa, Keiichi Kadoyama, Takashi Inui.   

Abstract

We have previously shown that matrix metalloproteinases (MMPs) play a role in osteoclastic bone resorption by facilitating migration of osteoclastic cells toward bone surface through matrices. Of MMPs identified so far, MMP-9 is likely the most important proteinase for the action, since osteoclasts express this enzyme at a tremendously high level. However, no direct evidence has been provided to demonstrate its contribution to bone resorption. In this study, to address this point, we used an MMP-9 antisense phosphothiorate oligodeoxynucleotide (S-ODN), which was shown to inhibit the protein synthesis of MMP-9 efficiently. We demonstrated that the antisense S-ODN inhibited osteoclastic pit formation on matrigel-coated dentine slices in a concentration-dependent manner with a maximum reduction of total pit volume by 53% at 10 microM. These results, taken together, suggest that MMP-9 is involved in osteoclastic bone resorption process possibly by facilitating migration of osteoclasts through proteoglican-rich matrices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806280     DOI: 10.1016/j.lfs.2006.05.024

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

Review 1.  Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.

Authors:  Thomas J Wilson; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2007-11-26

2.  Osteoclasts are important for bone angiogenesis.

Authors:  Frank C Cackowski; Judith L Anderson; Kenneth D Patrene; Rushir J Choksi; Steven D Shapiro; Jolene J Windle; Harry C Blair; G David Roodman
Journal:  Blood       Date:  2009-11-03       Impact factor: 22.113

3.  miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.

Authors:  Chenyang Zhao; Weijia Sun; Pengfei Zhang; Shukuan Ling; Yuheng Li; Dingsheng Zhao; Jiang Peng; Aiyuan Wang; Qi Li; Jinping Song; Cheng Wang; Xiaolong Xu; Zi Xu; Guohui Zhong; Bingxing Han; Yan-Zhong Chang; Yingxian Li
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 4.  Tumor-stromal interactions in bone metastasis.

Authors:  Kalyan C Nannuru; Rakesh K Singh
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

5.  1α,25-Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow-derived macrophages.

Authors:  Dong Wang; Jian-Hong Gu; Yang Chen; Hong-Yan Zhao; Wei Liu; Rui-Long Song; Jian-Chun Bian; Xue-Zhong Liu; Yan Yuan; Zong-Ping Liu
Journal:  Exp Ther Med       Date:  2015-07-08       Impact factor: 2.447

6.  Mast cells and MMP-9 in the lamina propria during eruption of rat molars: quantitative and immunohistochemical evaluation.

Authors:  Paulo Sérgio Cerri; Jorge Alonso Pereira-Júnior; Natalia Barrionuevo Biselli; Estela Sasso-Cerri
Journal:  J Anat       Date:  2010-06-16       Impact factor: 2.610

7.  Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion.

Authors:  Bhavik Desai; Tao Ma; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

8.  High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

Authors:  Y Wittrant; Y Gorin; K Woodruff; D Horn; H E Abboud; S Mohan; S L Abboud-Werner
Journal:  Bone       Date:  2008-02-29       Impact factor: 4.398

9.  Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.

Authors:  Amy Tomita; Tatsuhiko Kasaoka; Takashi Inui; Minako Toyoshima; Hiroko Nishiyama; Hiromasa Saiki; Haruo Iguchi; Motowo Nakajima
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

10.  The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase.

Authors:  Toru Yamasaki; Wataru Ariyoshi; Toshinori Okinaga; Yoshiyuki Adachi; Ryuji Hosokawa; Shinichi Mochizuki; Kazuo Sakurai; Tatsuji Nishihara
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.